Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMA | AMGN | BMY | VRTX | GILD |
| Company | Adma Biologics | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 21.60 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 21.70 | 290.57 | 58.48 | 455.43 | 89.94 |
| Low | 20.87 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 21.41 | 290.29 | 58.31 | 449.99 | 89.59 |
| Change | +0.04 | +2.42 | +0.43 | -1.24 | +0.96 |
| % Change | +0.19% | +0.84% | +0.74% | -0.27% | +1.08% |
| Volume | 1,223,596 | 1,697,593 | 4,300,010 | 808,682 | 2,050,051 |
| 20-Day Average Volume | 3,830,811 | 2,827,044 | 12,232,043 | 1,308,807 | 7,424,813 |
| Previous Close | 21.37 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.47 | 307.44 | 55.93 | 479.24 | 90.88 |
| 20-Day Raw Stochastic | 70.92% | 28.18% | 71.30% | 6.98% | 27.93% |
| 20-Day Relative Strength | 59.76% | 36.90% | 61.12% | 40.88% | 53.37% |
| Weighted Alpha | +307.23 | +2.17 | +26.61 | +18.05 | +25.87 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 56% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.69% since 11/14/24 | -1.87% since 11/14/24 | -0.14% since 11/14/24 | -6.95% since 11/14/24 | -2.66% since 11/14/24 |
| Low | 18.90 on 11/18/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 21.69 on 11/21/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +36.68% since 10/21/24 | -8.31% since 10/21/24 | +12.09% since 10/21/24 | -5.80% since 10/21/24 | +3.91% since 10/21/24 |
| Low | 15.34 on 10/22/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 23.64 on 11/11/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +19.67% since 08/21/24 | -11.77% since 08/21/24 | +20.60% since 08/21/24 | -7.36% since 08/21/24 | +19.34% since 08/21/24 |
| Low | 15.33 on 10/21/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 23.64 on 11/11/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +122.40% since 05/21/24 | -7.76% since 05/21/24 | +38.21% since 05/21/24 | +1.89% since 05/21/24 | +33.24% since 05/21/24 |
| Low | 9.35 on 05/29/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 23.64 on 11/11/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,051,654 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 236,390 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 258,220,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -28,240,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 119,840,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 35,910,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.64 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 51.58 | 14.57 | 49.77 | 0.00 | 19.81 |